pharma · Advanced Or Metastatic Merkel Cell Carcinoma · Cutaneous Melanoma, Stage III · HURA
TuHURA Biosciences, Inc./NV
TuHURA Biosciences, Inc./NV clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Tampa, USA HQ
1996 Founded
32 Employees
Public company Type
HURA · NYSE Ticker
Company details
- Status
- Public
- HQ
- Tampa, USA
- Founded
- 1996
- Employees
- 32
- Programs
- 4
- Drugs
- 0
- Patents
- 0
TuHURA Biosciences, Inc./NV projects
0 ClinicalTrials.gov programs sponsored by TuHURA Biosciences, Inc./NV.
TuHURA Biosciences, Inc./NV has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does TuHURA Biosciences, Inc./NV have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.